Market Overview

UPDATE: Stifel Nicolaus Raises PT to $29 on Capital Senior Living; Growth Sustainable

Related CSU
Setback for Novartis - Analyst Blog
Update on Novartis' Xolair and Secukinumab - Analyst Blog

Stifel Nicolaus maintained Capital Senior Living (NYSE: CSU) with a Buy rating and raised the price target from $24.00 to $29.00.

Stifel Nicolaus noted, "CSU's growth from acquired assets in a fragmented seniors housing industry and good industry fundamental prospects continue to impress us. 4Q13 results exceeded our estimates and consensus estimates. Including benefits from additional internal growth and acquisitions in 2013 we are raising our 2013 CFFO estimate to $1.57/sh from $1.37/sh and price target to $29 from $0.24. Our revised price target equals 14.6x adjusted EV / 2013 EBITDAR, a slight premium to Buy-rated peers which we believe is warranted by Capital Senior's above average growth prospects."

Capital Senior Living closed at $24.07 on Wednesday.

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (CSU)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free